Company Filing History:
Years Active: 2022
Title: Naoto Hattori: Innovator in Controlled-Release Preparations
Introduction
Naoto Hattori is a distinguished inventor based in Kyoto, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled-release preparations. His innovative work has led to the creation of a patent that enhances the efficacy of drug delivery systems.
Latest Patents
Hattori holds a patent for a controlled-release preparation that contains 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsulfonyl)acetamide as an active ingredient. This preparation is designed to provide excellent release properties, ensuring that the active ingredient is delivered effectively over time. Additionally, the patent describes a formulation that includes a water-soluble polymer, a functional starch, and an alkaline substance, achieving a pH of 10 or more.
Career Highlights
Hattori is currently associated with Nippon Shinyaku Company, Ltd., where he continues to advance his research and development efforts. His work has been instrumental in improving drug formulations, which can lead to better patient outcomes.
Collaborations
Hattori collaborates with Shouji Furuta, a fellow researcher, to further enhance the development of innovative pharmaceutical solutions.
Conclusion
Naoto Hattori's contributions to controlled-release preparations exemplify the importance of innovation in the pharmaceutical industry. His work not only advances scientific knowledge but also has the potential to improve therapeutic efficacy for patients.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.